The High Court won’t hear Bayer’s appeal of an invalidity finding over patents for blood thinner Xarelto, despite the company’s claim the decision has “profound” consequences for drug R&D.
A failed competition class action by Queensland electricity customers accusing utility companies Stanwell and CS Energy of misusing their market power has been appealed to the Full Court.
As the High Court hears oral arguments this week on the reach of power to make common fund orders for firms and funders bringing class actions, Lawyerly gives a cheat sheet on what the justices could do.
Discount grocery giant Aldi has lodged an appeal after a court found its Mamia Baby Puffs copied the look of rival Little Bellies baby snacks.
The valuer general has knocked arguments by developer WSTI Properties in a High Court dispute over a heritage property in Melbourne, saying the contentions are “unavailable and unsound”.
EPC Pacific is facing a fight after it got the go-ahead from Yarra City Council to build an 11-storey mixed use office building in an inner city Melbourne suburb.
Otsuka Pharmaceuticals is challenging a decision revoking its patent for an injectable version of antipsychotic drug Abilify.
The High Court has been asked to overturn a ruling that found India was immune from a suit seeking to enforce a $111.3 million arbitral award because it did not involve a ‘commercial’ matter.
A former capital partner of HWL Ebsworth wants the High Court to overturn a finding that he was validly expelled from the partnership, arguing the firm’s conduct breached the Equal Opportunity Act.
Munich Reinsurance has been given the OK to bring additional claims in its $696 million lawsuit, which accuses AMP of misleading or deceptive conduct over a quota share agreement.